Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-09-001768
Filing Date
2009-11-23
Accepted
2009-11-23 16:30:54
Documents
2
Group Members
DANIEL S. LOEBJASON ARYEHTHIRD POINT ADVISORS II L.L.C.THIRD POINT OFFSHORE MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 13 n5266929b.txt SC 13D/A 29123
3 JOINT FILING AGREEMENT n5266929c.txt EX-99.4 2940
  Complete submission text file 0000899140-09-001768.txt   34569
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 091202064
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

EIN.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A